A phase plane graph based model of the ovulatory cycle lacking the "positive feedback" phenomenon

Theoretical Biology and Medical Modelling

Volumn 9, Issue 1, 2012, Pages

  Kurbel, Sven ^a  

^a JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ESTROGEN; ESTROGEN RECEPTOR; FOLLITROPIN; GONADORELIN RECEPTOR; INHIBIN; LEPTIN; LUTEINIZING HORMONE; PROGESTERONE; PROGESTERONE RECEPTOR;

BIOLOGICAL MODEL; EVOLUTION; FEEDBACK SYSTEM; FEMALE; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; LUTEOLYSIS; MALE; MENSTRUAL CYCLE; OVULATION; PHYSIOLOGY; PUBERTY; REVIEW; SEXUAL DEVELOPMENT;

ACTIVINS; BIOLOGICAL EVOLUTION; ESTROGENS; FEEDBACK, PHYSIOLOGICAL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; HYPOTHALAMUS; INHIBINS; LEPTIN; LUTEINIZING HORMONE; LUTEOLYSIS; MALE; MENSTRUAL CYCLE; MODELS, BIOLOGICAL; OVULATION; PITUITARY GLAND; PROGESTERONE; PUBERTY; RECEPTORS, ESTROGEN; RECEPTORS, LHRH; RECEPTORS, PROGESTERONE; SEX CHARACTERISTICS;

EID: 84864778662     PISSN: None     EISSN: 17424682     Source Type: Journal    
DOI: 10.1186/1742-4682-9-35     Document Type: Review

References (36)

1. The female reproductive system. DeCherney AH, Medical Physiology: A Cellular and Molecular Approach Philadelphia PA: Saunders, Boron WF, Boulpaep EL, 2 rev 2008 1146 1169
2. Barrett KE, Barman SM, Boitano S, Brooks HL, Ganong's Review of Medical Physiology, edn 23 New York: London: McGraw-Hill Medical 2009 22979338
3. Regulation of the human menstrual cycle. Chabbert Buffet N, Djakoure C, Maitre SC, Bouchard P, Front Neuroendocrinol 1998 19 3 151 186 10.1006/frne.1998.0167 9665835 (Pubitemid 28347695)
4. High-resolution reference ranges for Estradiol, luteinizing hormone, and follicle-stimulating hormone in men and women using the AxSYM assay system. Dighe AS, Moy JM, Hayes FJ, Sluss PM, Clin Biochem 2005 38 2 175 179 10.1016/j.clinbiochem.2004.10.011 15642281 (Pubitemid 40092461)
5. Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT analyzer. Stricker R, Eberhart R, Chevailler MC, Quinn FA, Bischof P, Stricker R, Clin Chem Lab Med 2006 44 7 883 887 16776638
6. The human menstrual cycle: plasma concentrations of prolactin, LH, FSH, oestradiol and progesterone in conceiving and non-conceiving women. Lenton EA, Sulaiman R, Sobowale O, Cooke ID, J Reprod Fertil 1982 65 1 131 139 10.1530/jrf.0.0650131 6804627 (Pubitemid 12093332)
7. A longitudinal study of serum lipoproteins in relation to endogenous reproductive hormones during the menstrual cycle: findings from the BioCycle study. Mumford SL, Schisterman EF, Siega-Riz AM, Browne RW, Gaskins AJ, Trevisan M, Steiner AZ, Daniels JL, Zhang C, Perkins NJ, Wactawski-Wende J, J Clin Endocrinol Metab 2010 95 9 80 E85 10.1210/jc.2010-0109 20534764
8. Hormonal characteristics of the human menstrual cycle throughout reproductive life. Sherman BM, Korenman SG, J Clin Invest 1975 55 4 699 706 10.1172/JCI107979 1120778
9. Plasma gonadotrophin and ovarian steroid concentrations in women with menstrual cycles with a short luteal phase. Smith SK, Lenton EA, Cooke ID, J Reprod Fertil 1985 75 2 363 368 10.1530/jrf.0.0750363 3934365 (Pubitemid 16220696)
10. Circadian rhythm of blood leptin level in obese and non-obese people. Radi R, Nikoli V, Karner I, Kosovi P, Kurbel S, Selthofer R, Curkovi M, Coll Antropol 2003 27 2 555 561 14746143 (Pubitemid 39118042)
11. Inertia of endocrine systems due to hormone binding to circulatory proteins. Kurbel S, Zuci D, Kurbel B, Gulam D, Gmajni R, Krajina Z, Med Hypotheses 2003 60 3 430 438 10.1016/S0306-9877(02)00421-8 12581625 (Pubitemid 36237977)
12. Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women. Wunder DM, Bersinger NA, Yared M, Kretschmer R, Birkhäuser MH, Fertil Steril 2008 89 4 927 933 10.1016/j.fertnstert.2007.04.054 17603052 (Pubitemid 351491234)
13. Minireview: kisspeptin neurons as central processors in the regulation of gonadotropin-releasing hormone secretion. Dungan HM, Clifton DK, Steiner RA, Endocrinology 2006 147 3 1154 1158 16373418 (Pubitemid 43244347)
14. Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen. Horwitz KB, Koseki Y, McGuire WL, Endocrinology 1978 103 5 1742 1751 10.1210/endo-103-5-1742 748014 (Pubitemid 9051866)
15. Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. Clark GM, Osborne CK, McGuire WL, J Clin Oncol 1984 2 10 1102 1109 6491696 (Pubitemid 14022697)
16. The influence of progestins on receptor levels in breast cancer metastasis. Lundgren S, Kvinnsland S, Varhaug JE, Utaaker E, Anticancer Res 1987 7 1 119 123 3032071
17. Influence of tamoxifen-medroxyprogesterone sequential therapy on estrogen and progesterone receptor contents of breast cancer. Noguchi S, Yamamoto H, Inaji H, Imaoka S, Koyama H, Jpn J Cancer Res 1989 80 3 244 248 10.1111/j.1349-7006.1989.tb02300.x 2524460 (Pubitemid 20027216)
18. Effect of onapristone and medroxyprogesterone acetate on the proliferation and hormone receptor concentration of human breast cancer cells. Classen S, Possinger K, Pelka-Fleischer R, Wilmanns W, J Steroid Biochem Mol Biol 1993 45 4 315 319 10.1016/0960-0760(93)90348-Z 8499339 (Pubitemid 23166565)
19. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause. Pujol P, Daures JP, Thezenas S, Guilleux F, Rouanet P, Grenier J, Cancer 1998 83 4 698 705 10.1002/(SICI)1097- 0142(19980815)83:4<698::AID-CNCR10>3.0.CO;2-N 9708933 (Pubitemid 28387692)
20. Progesterone receptor A and B messenger ribonucleic acid levels in the anterior pituitary of rats are regulated by estrogen. Szabo M, Kilen SM, Nho SJ, Schwartz NB, Biol Reprod 2000 62 1 95 102 10.1095/biolreprod62.1.95 10611072 (Pubitemid 30013473)
21. Immunocytochemical analysis of oestrogen receptors and progesterone receptors in the human uterus throughout the menstrual cycle and after the menopause. Snijders MP, de Goeij AF, Debets-Te Baerts MJ, Rousch MJ, Koudstaal J, Bosman FT, J Reprod Fertil 1992 94 2 363 371 10.1530/jrf.0.0940363 1593539
22. Down-regulated progesterone receptor A and B coinciding with successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system. Orbo A, Arnes M, Pettersen I, Larsen K, Hanssen K, Moe B, Acta Obstet Gynecol Scand 2010 89 11 1438 1446 10.3109/00016349.2010.512068 20955098
23. Estradiol receptor levels in rat hypothalamic and limbic nuclei. Rainbow TC, Parsons B, MacLusky NJ, McEwen BS, J Neurosci 1982 2 10 1439 1445 7119866 (Pubitemid 13255861)
24. Progestin receptor levels in rat hypothalamic and limbic nuclei. Parsons B, Rainbow TC, MacLusky NJ, McEwen BS, J Neurosci 1982 2 10 1446 1452 6889633 (Pubitemid 13255862)
25. Changes in the binding of oestradiol to uterine oestrogen receptors induced by some progesterone and 19-nor-testosterone derivatives. Di Carlo F, Gallo E, Conti G, Racca S, J Endocrinol 1983 98 3 385 389 10.1677/joe.0.0980385 6194237 (Pubitemid 13020958)
26. Effects of long-term administration of high doses of medroxyprogesterone acetate on hormone receptors and target organs in the female rat. Di Carlo F, Racca S, Conti G, Gallo E, Muccioli G, Sapino A, Bussolati G, J Endocrinol 1984 103 3 287 293 10.1677/joe.0.1030287 6094695 (Pubitemid 15208326)
27. Localization of oestrogen receptor alpha, oestrogen receptor beta and androgen receptors in the rat reproductive organs. Pelletier G, Labrie C, Labrie F, J Endocrinol 2000 165 2 359 370 10.1677/joe.0.1650359 10810300 (Pubitemid 30341085)
28. Contraception. Glasier A, Endocrinology Philadelphia: Elsevier Saunders, DeGroot LJ, Jameson JL, 5 2006 2993 3003
29. Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia. Vereide AB, Kaino T, Sager G, Arnes M, Orbo A, Gynecol Oncol 2006 101 2 214 223 10.1016/j.ygyno.2005.10.030 16325240
30. Low dose pulsatile gonadotropin-releasing hormone in anorexia nervosa: a model of human pubertal development. Marshall JC, Kelch RP, J Clin Endocrinol Metab 1979 49 5 712 718 10.1210/jcem-49-5-712 385613 (Pubitemid 10198303)
31. Serum leptin and gonadotropin levels in patients with anorexia nervosa during weight gain. Ballauff A, Ziegler A, Emons G, Sturm G, Blum WF, Remschmidt H, Hebebrand J, Mol Psychiatry 1999 4 1 71 75 10.1038/sj.mp.4000478 10089013
32. Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial. Plourde PV, Reiter EO, Jou HC, Desrochers PE, Rubin SD, Bercu BB, Diamond FB Jr, Backeljauw PF, J Clin Endocrinol Metab 2004 89 9 4428 4433 10.1210/jc.2004-0082 15356042 (Pubitemid 39244450)
33. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels. Leder BZ, Rohrer JL, Rubin SD, Gallo J, Longcope C, J Clin Endocrinol Metab 2004 89 3 1174 1180 10.1210/jc.2003-031467 15001605 (Pubitemid 38368408)
34. Treatment of male infertility secondary to morbid obesity. Roth MY, Amory JK, Page ST, Nat Clin Pract Endocrinol Metab 2008 4 7 415 419 10.1038/ncpendmet0844 18523426 (Pubitemid 351881863)
35. Human adiposity, longevity and reproduction features as consequences of population bottlenecks. Kurbel S, Zuci D, Med Hypotheses 2008 70 5 1054 1057 10.1016/j.mehy.2007.08.027 17976925 (Pubitemid 351400703)
36. Pleiotropy, natural selection, and the evolution of senescence. Williams GC, Evolution 1957 11 4 398 411 10.2307/2406060